Foreword

Armed conflicts, budgetary restrictions and new rules imposed by economic partners are putting Belgium under severe pressure. For the first time in years, we are seeing a decline in key areas such as employment, patent applications, investment in research and development, and exports.

The choices we make today will determine our future. The time has come to show vision and determination. Our country is facing important choices. 

For example, we must focus more on prevention. HPV vaccination is a good example. It prevents 12 000 premature deaths and 
430 000 hours of care in Europe every year. Investing in prevention means investing in well-being and a healthy society.

It is also essential to focus on health in general. Every euro invested in health and new breakthrough treatments yields up to 4 euros in health gains. Smart choices strengthen society, employment, research and economic growth. 

Let us also be realistic: life-saving therapies cannot be offered at clearance prices. Investments in innovation deserve our recognition and support.

Belgium and Europe have everything they need not only to maintain their pioneering role in science and biopharmaceuticals, but also to strengthen it. Vision, determination and cooperation will enable us to shape a future where everyone wins within the vast healthcare ecosystem.

Discover the role of our sector in this regard in pharma.be’s fifth Report to Society.